PHASE II STUDY EVALUATING THE ACTIVITY AND TOXICITY OF A BIWEEKLY SCHEDULE OF GEMCITABINE AND PACLITAXEL IN ANTHRACYCLINE-PRETREATED BREAST CANCER

被引：0
|
作者：
Spinelli, G. P. [1 ]
Di Seri, M. [1 ]
Mezi, S. [1 ]
Oliveti, A. [1 ]
Tomao, F. [1 ]
Petricola, F. [1 ]
Rosati, S. [1 ]
Ricciardi, S. [1 ]
Coletta, D. [1 ]
Romiti, A. [1 ]
Frati, L. [1 ]
Tomao, S. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [11] Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
    Mavroudis, D
    Malamos, N
    Alexopoulos, A
    Kourousis, C
    Agelaki, S
    Sarra, E
    Potamianou, A
    Kosmas, C
    Rigatos, G
    Giannakakis, T
    Kalbakis, K
    Apostolaki, F
    Vlachonicolis, J
    Kakolyris, S
    Samonis, G
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 211 - 215
  • [12] A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer
    von Minckwitz, G
    Jonat, W
    Fasching, P
    du Bois, A
    Kleeberg, U
    Lück, HJ
    Kettner, E
    Hilfrich, J
    Eiermann, W
    Torode, J
    Schneeweiss, A
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 89 (02) : 165 - 172
  • [13] Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients
    Zelek, L
    Cottu, P
    Tubiana-Hulin, M
    Vannetzel, JM
    Chollet, P
    Misset, JL
    Chouaki, N
    Marty, M
    Gamelin, E
    Culine, S
    Dieras, V
    Mackenzie, S
    Spielmann, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2551 - 2558
  • [14] A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer
    Gunter von Minckwitz
    Walter Jonat
    Peter Fasching
    Andreas du Bois
    Ulrich Kleeberg
    Hans-Joachim Lück
    Erika Kettner
    Jörn Hilfrich
    Wolfgang Eiermann
    Julie Torode
    Andreas Schneeweiss
    Breast Cancer Research and Treatment, 2005, 89 : 165 - 172
  • [15] Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
    Vici, Patrizia
    Fabi, Alessandra
    Metro, Giulio
    Sergi, Domenico
    Giannarelli, Diana
    Di Lauro, Luigi
    Bepler, Gerold
    Tomao, Federica
    Cognetti, Francesco
    Conti, Francesca
    Lopez, Massimo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 687 - 693
  • [16] Docetaxel/gemcitabine: Salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer
    Georgoulias, VA
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 18 - 24
  • [17] A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
    Tomao, Silverio
    Romiti, Adriana
    Tomao, Federica
    Di Seri, Marisa
    Caprio, Giuliana
    Spinelli, Gian Paolo
    Terzoli, Edmondo
    Frati, Luigi
    BMC CANCER, 2006, 6 (1)
  • [18] A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
    Silverio Tomao
    Adriana Romiti
    Federica Tomao
    Marisa Di Seri
    Giuliana Caprio
    Gian Paolo Spinelli
    Edmondo Terzoli
    Luigi Frati
    BMC Cancer, 6
  • [19] Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer
    Stathopoulos, GP
    Rigatos, SK
    Pergantas, N
    Tsavdarides, D
    Athanasiadis, I
    Malamos, NA
    Stathopoulos, JG
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 37 - 41
  • [20] Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer
    Chan, Stephen
    Romieu, Gilles
    Huober, Jens
    Delozier, Thierry
    Tubiana-Hulin, Michele
    Schneeweiss, Andreas
    Lluch, Ana
    Llombart, Antonio
    du Bois, Andreas
    Kreienberg, Rolf
    Mayordomo, Jose Ignacio
    Anton, Antonio
    Harrison, Mark
    Jones, Alison
    Carrasco, Eva
    Vaury, A. Thareau
    Frimodt-Moller, Bente
    Fumoleau, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) : 1753 - 1760
12345